Brief: Nuvectis Pharma, Inc. Reports 2025 Financial Results And Business Highlights
Feb 11 (Reuters) - Nuvectis Pharma Inc NVCT.O: NUVECTIS PHARMA, INC. REPORTS 2025 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS Source text: ID:nGNX3Nr9KM Further company coverage: NVCT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nuvectis Pharma
See all newsNuvectis Pharma Inc reports results for the quarter ended June 30 - Earnings Summary
Nuvectis Pharma Inc expected to post a loss of 26 cents a share - Earnings Preview
Brief: Ciprocopan (NXP100) Receives Marketing Approval In China For The Treatment Of Patients With PNH Previously Untreated With Complement Inhibitors
U.S. STOCKS ON THE MOVE-Chip stocks, Unicycive, Roblox
U.S. STOCKS ON THE MOVE-AMD, Roblox, Olin